Sponsor Pipeline

Beacon Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT02599922
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A…
overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 2/3
1
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT04850118 A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of… X-Linked Retinitis Pigmentosa Active, Not Recruiting
Phase 2
NCT06333249 A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis… X-Linked Retinitis Pigmentosa Active, Not Recruiting
NCT06275620 A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis… X-Linked Retinitis Pigmentosa Enrolling by Invitation
NCT07174726 A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec… X-Linked Retinitis Pigmentosa (XLRP) Active, Not Recruiting
Phase 1/2
NCT02935517 Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A… Achromatopsia Active, Not Recruiting
Get alerts when Beacon Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free